Thermo Fisher Scientific Inc (NYSE:TMO) Position Boosted by Highbridge Capital Management LLC

Highbridge Capital Management LLC boosted its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 45.3% during the first quarter, Holdings Channel reports. The institutional investor owned 11,688 shares of the medical research company’s stock after buying an additional 3,642 shares during the period. Highbridge Capital Management LLC’s holdings in Thermo Fisher Scientific were worth $1,795,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of Thermo Fisher Scientific by 2.7% in the first quarter. Vanguard Group Inc. now owns 25,971,301 shares of the medical research company’s stock worth $3,989,193,000 after buying an additional 695,079 shares in the last quarter. BlackRock Inc. boosted its stake in shares of Thermo Fisher Scientific by 2,692.1% in the first quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock worth $3,531,095,000 after buying an additional 22,165,530 shares in the last quarter. State Street Corp boosted its stake in shares of Thermo Fisher Scientific by 1.0% in the first quarter. State Street Corp now owns 16,085,954 shares of the medical research company’s stock worth $2,470,802,000 after buying an additional 164,367 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Thermo Fisher Scientific by 5.6% in the first quarter. Wellington Management Group LLP now owns 7,512,152 shares of the medical research company’s stock worth $1,153,867,000 after buying an additional 398,622 shares in the last quarter. Finally, Morgan Stanley boosted its stake in shares of Thermo Fisher Scientific by 7.6% in the first quarter. Morgan Stanley now owns 4,664,882 shares of the medical research company’s stock worth $716,526,000 after buying an additional 327,826 shares in the last quarter. Hedge funds and other institutional investors own 87.15% of the company’s stock.

Thermo Fisher Scientific Inc (TMO) traded up 0.82% during trading on Friday, reaching $173.15. 455,456 shares of the company were exchanged. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $182.87. The stock has a market capitalization of $67.55 billion, a price-to-earnings ratio of 30.17 and a beta of 1.06. The firm’s 50 day moving average price is $176.85 and its 200-day moving average price is $165.24.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.27 by $0.03. The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The firm’s quarterly revenue was up 10.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.03 EPS. On average, equities research analysts predict that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 10.45%.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://www.com-unik.info/2017/08/11/thermo-fisher-scientific-inc-nysetmo-position-boosted-by-highbridge-capital-management-llc.html.

A number of analysts have commented on TMO shares. Bank of America Corporation reiterated a “buy” rating and issued a $210.00 price target (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Friday, July 21st. Zacks Investment Research cut shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Barclays PLC set a $175.00 price target on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Wednesday, April 26th. Cantor Fitzgerald started coverage on shares of Thermo Fisher Scientific in a research note on Thursday, May 18th. They issued an “overweight” rating and a $194.00 price target for the company. Finally, Cowen and Company reiterated an “outperform” rating and issued a $185.00 price target (up previously from $175.00) on shares of Thermo Fisher Scientific in a research note on Saturday, April 29th. One equities research analyst has rated the stock with a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $188.56.

In related news, CEO Marc N. Casper sold 20,000 shares of the business’s stock in a transaction dated Thursday, June 1st. The shares were sold at an average price of $172.79, for a total value of $3,455,800.00. Following the transaction, the chief executive officer now directly owns 269,279 shares of the company’s stock, valued at approximately $46,528,718.41. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Daniel P. Shine sold 4,688 shares of the business’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $171.88, for a total transaction of $805,773.44. Following the completion of the transaction, the insider now directly owns 29,200 shares in the company, valued at $5,018,896. The disclosure for this sale can be found here. Insiders sold a total of 27,188 shares of company stock worth $4,702,223 over the last three months. 0.49% of the stock is owned by insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit